The first batch of HArmonyCa™ is delivered to Hong Kong Medical! HArmonyCa™ is the first dual-effect hybrid injectable newly introduced by Allergan Aesthetics, an AbbVie Company, a global leader in medical aesthetic treatments and maker of Juvéderm®.

HArmonyCa^TM is created by advanced technology in mixing hyaluronic acid (HA) with calcium hydroxyapatite (CaHA) in a stepwise manner, providing benefits of an immediate lift effect and sustained collagen stimulation with a distinctive C-Shape approach, bringing about an improvement in skin firmness.

Sustained lifting effect from new collagen production with HArmonyCaTM
	✔ Newly formed collagen fibres are present around injection site as early as week 1.
	✔HArmonyCa demonstrates greater tissue infiltration than CaHA during week 1.
	✔HArmonyCa provides a significantly higher lifting effect than CaHA from week 2 to 12.
	✔Contains 0.3% lidocaine hydrochloride to reduce pain during treatment.